Drugs Made In America Acquisition Income Statement (2024-2025) | DMIIR

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2024 Sep2025 Dec2025
Operating items
Selling, General & Administrative (Quarter) 0.16M0.24M
Operating Expenses (Quarter) 0.16M0.24M
Operating Income (Quarter) -0.16M-0.24M
EBIT (Quarter) -0.16M-0.24M
Non-operating items
Interest & Investment Income (Quarter) 0.11M4.82M
Non Operating Income (Quarter) 0.11M4.57M
Net income details
EBT (Quarter) -0.05M4.59M
Profit After Tax (Quarter) -0.05M4.33M
Income from Continuing Operations (Quarter) -0.05M4.59M
Consolidated Net Income (Quarter) -0.05M4.59M
Income towards Parent Company (Quarter) -0.05M4.59M
Net Income towards Common Stockholders (Quarter) -0.01M2.31M
Additional items
EPS (Basic) (Quarter) 0.000.17
EPS (Weighted Average and Diluted) (Quarter) 0.000.16
Shares Outstanding (Weighted Average) (Quarter) 12.50M2.72M12.82M
Shares Outstanding (Diluted Average) (Quarter) 12.50M2.72M14.43M
EBITDA (Quarter) -0.16M-0.24M